查詢結果分析
來源資料
相關文獻
- Survival Rate for Liver Cancer in Taiwan
- 肝癌的成因及危險因子
- 肝癌病患家屬參加教育心理團體成效探討
- N-Acetyltransferase in Healthy Human Liver and Hepatoma Tissues
- Use of Color Ultrasound in Percutaneous Intravascular Ethanol Injection into the Supplying Vessel of a Hepatocellular Carcinoma: Report of a Case
- 小型肝癌併腦部轉移
- Hepatocellular Carcinoma Presenting with Acquired Porphyria: A Case Report and Review of the Literature
- Evaluation of a Simplified Staging System for Prognosis of Hepatocellular Carcinoma
- 肝癌的危險因子
- Carcinosarcoma of the Liver: Report of a Case
頁籤選單縮合
題 名 | Survival Rate for Liver Cancer in Taiwan=臺灣肝癌5年存活率之研究 |
---|---|
作 者 | 李正亮; 葛應欽; 鍾全生; | 書刊名 | 中華醫學雜誌 |
卷 期 | 63:1 2000.01[民89.01] |
頁 次 | 頁16-20 |
分類號 | 415.536 |
關鍵詞 | 癌症登記; 肝癌; Cancer registry; Liver cancer; Survival; |
語 文 | 英文(English) |
中文摘要 | 背景:研究全國性肝癌5年的存活率。 方法:在1987年我們收集了在癌症登記資料上診斷為肝癌(ICD-155)之所有病人的資料,共收得2,558位病人,其中扣除485位無身份證字號、9位由於為金門及馬祖居民而無法追蹤其存活狀態、29 位無年齡記錄及33位轉移性肝癌病人,因此共有2,002位病人列入本研究,並追蹤其存活狀態。我們將這2,002位病人的身份證字號輸入電腦,然後再與衛生署的全國死亡資料之電腦檔案進行配對,從而獲知這2,002位病人有否死於1987-1992 年間。5年存活率的算法是使用actuarial life table。 結果:這2,002位肝癌病人中,依據組織病理診斷的有752位〔其中hepatocellular carcinoma(HCC)有600位〕,而依據臨床診斷的有1,250位。2,002位病人的5年存活率為 15%,依據組織病理診斷的病人之5年存活率為17%,而依據臨床診斷的病人之5年存活率為13%。5年存活率不因性別、年齡、居住地及種族而有所不同,而只受組織病理診斷所影響。依據組織病理診斷的660位HCC病人比未依據組織病理診斷者的5年存活率高。 結論:臺灣肝癌5年存活率為15%,且預後非常差。因此,加強病人接受治療及提高療效,將是國人努力的目標。 |
英文摘要 | Background: There is no nationwide population-based study of the survival rate for liver cancer in Taiwan. Consequently, the true rate of liver cancer survival is unknown. Our aim was to determine the survival rate for liver cancer patients in Taiwan. Method: The Taiwan Cancer Registry was searched for liver cancer cases in 1987 and 2,558 cases were found. Of these, 485 lacked an identification number, 29 lacked documentation of age, 33 were metastatic, nine lived in Kinmen and Lienkiang Hsien of Fukien Province leaving 2,002 to be studied. With the help of identification numbers, we linked our cases with the Death Registry of the Department of Health, Executive Yuan, ROC, for the 1987 to 1992 period and calculated the five-year survival rate using actuarial life tables. For analyzing factors affecting the five-year survival rate, multivariate analysis with the Cox proportional hazards model was used. Results: Of the 2,002 patients, 752 were diagnosed histopathologically and 1,250 patients were diagnosed clinically. A total of 15% of patients survived or five years or longer after diagnosis. Of those diagnosed histopathologically, 17% survived for five or more years, and of those diagnosed clinically, 13% survived for five or more years. The sex, age, residential area and ethnic origin did not affect the five-year survival rate significantly. Only diagnosis type affected the five-year survival rate significantly (p<0.05). The 660 pathologically diagnosed liver cancer patients had a better survival rate than the 1,250 patients diagnosed clinically. Conclusions: The overall five-year survival rate for liver cancer in Taiwan was 15%. The prognosis for liver cancer patients in Taiwan is still unfavorable. The aim is to persuade affected patients to accept treatment. |
本系統中英文摘要資訊取自各篇刊載內容。